Wednesday, October 15, 2025 | 13:00-16:00 CEST | Prague Congress Centre

We are pleased to invite you to the EANO Tumor Board: Multidisciplinary management of patients with glioma, taking place in Prague on October 15, 2025 from 13:00-16:00 CEST at the Prague Congress Centre. 
The event is free for EANO members, but registration is required as spaces are limited.

This event seeks to promote the multidisciplinary management of glioma patients, which is critical to ensure that patients receive appropriate treatment and care at the right time, in order to maximize survival and quality of life. The program consists of three multidisciplinary case-based discussions around the management of patients with glioma, combined with short lectures focusing on the practical aspects, emphasizing the evidence base that underpins management decisions. Case discussions will be led by a multidisciplinary panel of experts, with the audience encouraged to participate in the discussion. The event is aimed at residents, medical specialists, and nurses working in the field of neuro-oncology. 

Click the link here to view the full program.

Time & date: Wednesday, October 15, 2025, from 13:00 to 16:00 CEST
Where: Prague, Czech Republic
Venue: Prague Congress Centre, 5. kvetna 1640/65, Nusle, 140 21 Prague 4, CZ
Registration fee: Free for all EANO Members
Registration deadline: Friday, October 3, 2025, 23:59 CEST

Wednesday, October 15, 2025 | 13:00-17:30 CEST | Prague Congress Centre

We are pleased to invite you to the FREE-TO-ATTEND GLIORESOLVE Satellite meeting, taking place in Prague on October 15, 2025 from 13:00-17:30 CEST at the Prague Congress Centre.

This special event will feature keynote talks from leading international experts, including Prof. Patrick Wen (Harvard Medical School, Dana-Farber Cancer Institute), Prof. Gabriele Bergers (VIB KU Leuven), Prof. Anna Dimberg (Uppsala University), and Dr. Kate Connor (Trinity College Dublin).

The programme will focus on major advances in glioblastoma (GBM) research, particularly relating to the tumour microenvironment (TME). Topics will include the identification of novel TME subtypes and their potential as biomarkers for immunotherapy as well as other emerging therapeutic approaches, strategies to target the vascular phenotype to reduce GBM spread, and updates on new therapies for gliomas being studied in early clinical trials.

Alongside the invited lectures, three GLIORESOLVE Fellows will present insights from disruptive projects focused on the GBM TME. To foster discussion and networking, the day will also include a poster session and a light lunch for all attendees (13:00-14:00 CEST).

***This event is free to attend, but registration is required for planning purposes***

We look forward to welcoming you to Prague for what promises to be a dynamic and inspiring exchange of ideas in GBM research.

GLIORESOLVE is a European translational research consortium dedicated to improving treatment options for GBM patients. Through ten individual research projects, the consortium is applying a novel TME classification framework (link here) to develop new, more effective treatment strategies, including rationally selected immunotherapies. More information is available at www.glioresolve.eu. GLIORESOLVE is funded by the European Union's Horizon Europe research and innovation programme under the Marie Skłodowska-Curie Doctoral Networks grant agreement No 101073386 (GLIORESOLVE).